Antisecretory Factor Glioblastoma Phase 2
Clinical trial NCT05669820 · RECRUITING
Trial details
- NCT number
- NCT05669820
- Sponsor
- Peter Siesjö
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-15
- Primary completion
- 2026-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.